Labcorp Holdings Inc. LH, or Labcorp, is slated to report its fourth-quarter 2024 results on Feb. 6 before the opening bell.

Barclays analyst Luke Sergott raised the firm’s price target on Labcorp (LH) to $271 from $249 and keeps an Equal Weight rating on the shares.

Beyond analysts' top -and-bottom-line estimates for Labcorp (LH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...

Labcorp, on First Avenue, has celebrated the opening of 110,000 square feet of laboratory space and a warehouse and logistics ...

Labcorp Holdings Inc. (NYSE:LH), a prominent $20.8 billion healthcare diagnostics company, announced today an expansion of its credit facilities, underscoring the company's ongoing financial strategy.

Supreme Court agrees to consider stopping class action lawsuit that accuses Labcorp Holdings unit of discrimination because ...

Labcorp Holdings Inc. closed 1.61% short of its 52-week high of $247.99, which the company reached on November 11th.

Labcorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. We recently compiled a list of th ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, has once again been named to ...